Recent Headlines
Within Pharmaceuticals
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016
DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its portfolio. - February 26, 2016 - DelveInsight
Recursion Pharmaceuticals Supports White House Precision Medicine Initiative
Recursion Pharmaceuticals today announced that it is part of a group of nationally recognized private and public institutions making commitments as part of President Obama's Precision Medicine Initiative to rapidly find new treatments for ultra-rare genetic diseases. - February 25, 2016 - Recursion Pharmaceuticals
Makers Nutrition Hires Stephen Finnegan as General Manager
Rapidly growing nutraceutical company turns to seasoned executive to help lead expansion. - February 25, 2016 - Makers Nutrition, LLC
Signal Transducer and Activator of Transcription 3 (STAT3) Inhibitors Pipeline Insights, 2016
DelveInsight, the leading market research and consulting company has added new report STAT3 inhibitors-Pipeline Insights, 2016 to its portfolio. With this launch Delveinsight now has 700+ Reports on Indication Pipeline Insight. In addition to this DelveInsight’s research expertise provides the clients with up to date information of market till date order has been placed. - February 25, 2016 - DelveInsight
Indication-Market Insights, Epidemiology and Market Forecast - 2010-2020
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products. - February 25, 2016 - DelveInsight
Wego Health to Demonstrate the Importance of Patient Influencers During ePharma Summit 2016
Company will ask for a single question to show how the pharmaceutical industry can benefit from engaging patient community leaders. - February 24, 2016 - Wego Health
IQ4I Research & Consultancy Published a New Report on “Vascular Closure Devices Global Market – Forecast To 2022”
IQ4I’s Report Contains 73 market data tables and 35 figures spread through 205 pages and an exhaustive TOC on “Vascular Closure Devices Global Market [Type (Active {Clips, Suture-mediated devices & Plugs [Collagen based, Polymer based, Femoral Introducer Sheath and Hemostasis Device (FISH)]} & Passive {Hemostatic Pads/Patches & Compression devices}); Intervention (Diagnostic & Therapeutic); Access (Femoral & Radial); Regional (North America, Europe, Asia Pacific and Rest of the World)] - February 24, 2016 - IQ4I Research & Consultancy Pvt. Ltd.
MR Solutions Brings New 3D, 1000X Magnification Imaging Modality to Preclinical Research
MR Solutions’ new 3D in vivo confocal microscope for use in preclinical research provides a magnification range of up to 1000 times, allowing researchers to examine cellular details within a live small animal eliminating the need for a surgical biopsy - saving time and substantially reducing costs. - February 24, 2016 - MR Solutions
ALPCO's New NT-proBNP ELISA Offers Cost Savings and Flexibility
ALPCO recently announced the release of its new NT-proBNP (1-76) ELISA, offering researchers investigating cardiovascular disease, kidney disease, and diabetes with a flexible, user friendly and cost effective tool. The assay is highly characterized to measure changes in levels of NT-proBNP, and... - February 23, 2016 - ALPCO
AdvantaPure(R) Introduces AdvantaFlex® Sterile Molded Tubing Ends to Add Versatility to Tubing
Single-Use, molded, mini Tri-Clamp tubing ends are designed to improve production and reduce operational costs involved with biopharma processes. Made from AdvantaFlex biopharmaceutical grade TPE tubing and an overmolding process, the ends are well suited for aseptic fluid transfer applications. They reduce the potential for leaks and help simplify cleaning and validation procedures. AdvantaFlex Molded Tubing Ends are compatible with sterile tubing welders. - February 21, 2016 - AdvantaPure
Saint-Gobain Seals Opens Large Diameter, OmniSeal® Seal Production Facility in Kontich, Belgium
Saint-Gobain Seals has opened a new large diameter seal production facility at its Kontich, Belgium site in order to further improve quality and reduce lead-times significantly for large diameter, polymer OmniSeal® seals. With this new production facility, Saint-Gobain Seals aims to strengthen... - February 20, 2016 - Saint-Gobain Performance Plastics, Seals Group
PD-1 and PD-L 1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016
DelveInsight has a strong presence in the Oncology market with 100+ Reports on Oncology based Indications & Mechanism of Action (MOA). DelveInsight Report, PD-1 and PD-L 1 Inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016 has received great response and feedback from clients. - February 19, 2016 - DelveInsight
BFTP Announces Second Investment in Series A Funding for CRO Analytics
Additional investment based on positive results of the Pilot to Production program for company’s Clinical Trial Performance System, PerformerTM. - February 19, 2016 - CRO Analytics
Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016
DelveInsight, the leading market research and consulting company has added a new report “Antibody Drug Conjugate Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape, 2016” to its portfolio. - February 19, 2016 - DelveInsight
Fannin Innovation Studio Names Melissa Singh Principal
Life science commercialization company Fannin Innovation Studio (www.FanninInnovation.com) today promoted its first entrepreneur fellow, biomedical scientist Melissa Singh, Ph.D., to principal. With this move, entrepreneur fellow Erol Bakkalbasi, M.Sc. has been named senior entrepreneur... - February 17, 2016 - Fannin Partners, LLC
ImmunoReagents Introduces LigaTrap™ Purification Resins and Kits
ImmunoReagents is proud to announce LigaTrap™ purification resins and kits. LigaTrap™ technology utilizes novel, patented ligands, designed for antibody purification. Each kit includes 10 spin columns filled with LigaTrap™ resin and buffers needed to capture species-specific... - February 17, 2016 - ImmunoReagents Inc.
ALPCO Releases New Basophil Activation Test Validated for the Evaluation of Kinase Inhibitors in Early Drug Development
ALPCO has released its new InhibiScreen Basophil Activation Test (BAT) which was developed and validated specifically for the evaluation of kinase inhibitors during early drug development. - February 16, 2016 - ALPCO
Peptide Therapeutics: The Growing Hope for Metabolic Disorders
Roots Analysis has announced the addition of “Peptide Therapeutics in Metabolic Disorders, 2016-2025” report to its portfolio. The report provides a comprehensive study on the current market landscape and the future outlook of the evolving pipeline of peptide therapeutics that are being... - February 16, 2016 - Roots Analysis
Tabula Rasa Healthcare Pharmacy Simulation Software Tested by Schools of Pharmacy
Medication treatment is the most common medical intervention. Its imprecise use contributes to an estimated 45-50 million adverse drug events annually. Tabula Rasa's suite of software solutions provide prescribers, pharmacists and healthcare organizations with sophisticated and innovative tools to better manage the medication-related needs of patients. NiaRx provides electronic health record training and patient-case simulation for pharmacy students, the future of tomorrow's caregiving team. - February 15, 2016 - Tabula Rasa HealthCare
NuvOx Pharma receives FDA Orphan Drug Designation for Oxygen Therapeutic for Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of... - February 14, 2016 - NuvOx Therapeutics
Don Barbo Returns to VMG Health’s Business Valuation Practice
VMG Health welcomes back Don Barbo as a managing director in healthcare business valuation services. - February 13, 2016 - VMG Health
cliexa™ Launched Its first Rheumatoid Arthritis Disease Activity Tracking Mobile Application, cliexa-RA
Collaborative Network 4 Clinical Excellence, LLC (CN4CE) has just launched their first mobile chronic disease tracking application, cliexa-RA. cliexa-RA is available for iOS devices in the App Store. It tracks medications, symptoms and disease activity for Rheumatoid Arthritis. The Clinical... - February 13, 2016 - cliexa
NuvOx Pharma Announces FDA Acceptance of IND to Initiate Clinical Trial for Vaso-Occlusive Crisis in Sickle Cell Disease
The FDA has notified NuvOx Pharma that it may proceed with a clinical trial for its Investigational New Drug (IND), NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of sickle cell disease and it typically... - February 13, 2016 - NuvOx Therapeutics
Real Endpoints’ RxScorecard™ Predicted Launch Failure of Major New Anti-Cholesterol Drugs
Analysis from 2015 showed that because PCSK9 inhibitors had not proved more than incremental value for most patients, payers would dramatically restrict their usage. Poor Q4 sales show that’s exactly what happened. - February 12, 2016 - Real Endpoints
Fertility Preservation Network Welcomes Albuquerque, New Mexico Facility
Program greatly extends access to fertility preservation services - February 12, 2016 - ReproTech, LLC
Studies Use Epitope Diagnostics’ ELISA Kit to Establish Chromogranin A as a Potential Prognostic Marker in Prostate Cancer Patients Treated with Antiandrogens
Italian research group uses Epitope Diagnostics' Chromogranin A ELISA kit in study to determine CgA as a potential prognostic marker in castration-resistant prostate cancer patients treated in abiraterone or enzalutamide. - February 11, 2016 - Epitope Diagnostics, Inc.
Advanced Electrophoresis Solutions Signs an Exclusive Distributor Partner for Europe
AES (Advanced Electrophoresis Solutions Ltd.), a pioneer in designing and manufacturing the most reliable, high performance, and high throughput CEInfinite whole column imaging detection capillary isoelectric focusing (iCIEF) systems, proprietary cartridges, ampholytes, and pI standards for the... - February 11, 2016 - Advanced Electrophoresis Solutions Ltd.
PD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016
DelveInsight has made strong presence in Oncology market with 100+ Reports on Oncology-based Indications & Mechanism of Action (MOA). - February 10, 2016 - DelveInsight
Assessment Shows Nation’s Guard is Down Against Zika Virus and Mosquito-Borne Diseases
The Council of State and Territorial Epidemiologists (CSTE) supports President Barack Obama’s request of $1.8 billion to combat Zika virus. Declared a “global health emergency” by the World Health Organization, Zika virus increasingly threatens to spread local epidemics in the... - February 08, 2016 - Council of State and Territorial Epidemiologists
NanoCellect Closes $1.75M Series A Financing Round to Begin Production of the WOLF Cell Sorter
NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life sciences, will begin production of their WOLF Cell Sorter. The Series A investment was led by Ken Hood of San Diego’s FusionX Ventures, an early-stage investment fund. - February 08, 2016 - NanoCellect
Bioquark Inc. and Revita Life Sciences to Collaborate on Regenerative Medicine Applications in Spinal Cord Injury
Bioquark Inc., a cutting edge life sciences company focused on the development of a novel biologic portfolio of products, services, and technologies for complex regeneration, disease reversion, and aging in humans, is entering a collaboration with India's Revita Life Sciences to advance translational opportunities in spinal cord injury repair. - February 06, 2016 - Bioquark Inc.
Vivonics Sells Artificial Lung Technology
Vivonics, Inc. announced today the sale of intellectual property and other assets related to its Artificial Lung technology to Lung Biotechnology PBC, a wholly-owned subsidiary of United Therapeutics Corporation. Vivonics’ development of the Artificial Lung technology was supported by the... - February 04, 2016 - Vivonics, Inc.
Noninvasix Secures Finalist Slot in Healthcare Innovation Challenges
CEO Graham Randall to present patient monitoring device at SPIE Startup Challenge, Pediatric Device Innovation Competition. - February 03, 2016 - Noninvasix
New Company Providing Paint Services for Manufacturers Hosts Open House Showcasing Highly Automated Line in Cheney, Kansas
Albers Finishing & Solutions provides liquid paint services to regional and national customers. the liquid paint line is capable of painting 2,000 to 3,000 parts per day and features an automated conveyor that moves load bars forward and reverse or even stops them independently of the other load bars, a three-stage wash, dry off oven, two paint booths with Fanuc robots applying liquid primer and paint, a dual-lane energy-efficient cure oven and a load-assist lifter. - February 02, 2016 - Kasa Companies
Speaking of NEC Podcast Featuring Dr. Corrine Hanson Recently Launched
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts - neonatologists, clinicians and researchers - that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - February 02, 2016 - The Morgan Leary Vaughan Fund, Inc.
Coalition Forms to Study Medication Risk in Workforce Populations
Tabula Rasa HealthCare and The Greater Philadelphia Business Coalition on Health have partnered to examine the extent of medication risk in a diverse workforce population and the opportunities to mitigate that risk for the benefit of improving the health and welfare of employees and reducing unnecessary health care costs. - February 01, 2016 - Tabula Rasa HealthCare
Genelex Receives Innovative Technology Designation from Vizient, Inc. for YouScript® Software
Genelex receives Innovative Technology Designation from Vizient, Inc. for YouScript® software that reduces ER visits & hospitalizations with improved, gene-based medication management. Designation recognizes the development of new solutions that benefit the health care industry. - January 30, 2016 - Genelex Corp
International Equipment Trading Ltd. Relocates to Larger Office & Warehouse
International Equipment Trading Ltd.. (IET) recently moved its corporate headquarters to Mundelein, IL. The new office is approximately five miles from its previous location in Vernon Hills, IL. - January 30, 2016 - IET
aiaTranslations Offering Discounts to Healthcare Associations
As part of the annual patient access drive, aiaTranslations, the leader in life sciences translation services, is offering discounted translation pricing to patient advocacy and education non-profits. - January 29, 2016 - aiaTranslations LLC
Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Competitive Landscape, Technology and Pipeline Analysis, 2016
DelveInsight, the leading market research and consulting company has added new report “Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Technology and Pipeline Analysis, 2016” to its portfolio. CAR-T cells are the next targeted agents in Oncology. CAR-T... - January 29, 2016 - DelveInsight
ALPCO's New Stool-Based Gastroenterology Assays and Extraction Method Can Improve Lab Sample Processing Time by Up to 86%
ALPCO recently launched a new panel of 13 stool-based gastroenterology assays that are all compatible with one single extraction step, allowing labs to improve sample processing time by up to 86%. - January 26, 2016 - ALPCO
MyTabib.com Connects You to Thousands of Medical Service Providers Worldwide
In January, a new medical portal MyTabib.com was launched providing a global healthcare search platform for patients. MyTabib.com offers patients the ability to search for clinics and doctors around the world in which they can compare cost procedures, book appointments right away, write comments and read real patient reviews in the comfort of their own home using the internet. - January 26, 2016 - MyTabib
Use of Care Plans Boosts Patient Adherence, Engagement, Quality Metrics
The use of care plans improves medication adherence, patient self-management and clinical quality ratings, say a majority of respondents to a 2015 survey by the Healthcare Intelligence Network (HIN). - January 26, 2016 - Healthcare Intelligence Network
Eagle Biosciences Announces the Launch of Functional Leptin ELISA
An Esoteric Kit for Measurement of Functional, Receptor Binding Leptin Levels in Serum or Plasma - January 25, 2016 - Eagle Biosciences, Inc.
Pacific Ozone Appoints New Strategic Sales & Marketing Manager for Europe and Asia/Pacific
Pacific Ozone, a leading manufacturer of industrial ozone disinfection systems, named Henrik Steffens as its new Strategic Sales & Marketing Manager for Europe and Asia/Pacific (APAC). Mr. Steffens has 25 years of experience in technical sales and marketing in the agri-aquaculture, marine and ozone disinfection industries. He will be in charge of managing and expanding Pacific Ozone’s network of sales representatives and distributors in Europe and Asia. - January 23, 2016 - Pacific Ozone
Saint-Gobain Seals Presents Technical Paper on Cold Temperature Sealing at SAE A-5/A-6 Committee Meeting
Saint-Gobain Seals presented a technical paper at the SAE International Joint Technical Committee event titled, “Cold Temperature Hydraulic Seals for Aerospace Hydraulic Systems,” during the A-5B Struts and Couplings and A-6C2 Seals panels, and A-5/A-6 Joint Committee meeting. The... - January 23, 2016 - Saint-Gobain Performance Plastics, Seals Group
High Doses of Iron Salts in Traditional Iron Supplement Can Impede Absorption
Clinical trial results show conclude that high doses of iron salts found in conventional Iron supplements can decrease absorption. Naturally fermented Bio-Active Iron by Nutrexin provides an excellent alternative. - January 22, 2016 - Nutrexin USA
Children’s Healthcare of Atlanta Received $1M Research Grant from Enduring Hearts
Children’s Healthcare of Atlanta has received a generous grant of $1,000,000 from the Enduring Hearts Foundation to fund cardiac research to enhance the lives of children needing heart transplantation. Some of the research funded will be that of Michael Davis, Ph.D., Director of the... - January 22, 2016 - Enduring Hearts
International Society on Thrombosis and Haemostasis Releases New Clinical Core Curriculum to Aid Specialization of the Field
Journal of Thrombosis and Haemostasis publishes article on first internationally developed and reviewed Core Curriculum to guide clinical knowledge and training in the industry - January 21, 2016 - International Society on Thrombosis and Haemostasis (ISTH)
Asian Patent Acceptances Enhance Braasch Biotech Livestock Portfolio
New paradigm of using vaccines to enhance productivity in livestock, Braasch Biotech continues portfolio expansion - January 21, 2016 - Braasch Biotech LLC